To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

Improbable closes US defence business

13th December 2022 - 13:30 GMT | by Norbert Neumann in London

RSS

One question Improbable Defence is likely to face in the coming months is how the closure of its US business will affect its UK endeavours. (Photo: UK MoD Crown Copyright)

The British company's subsidiary Improbable Defense US will cease its American defence activities due to 'challenging macroeconomic conditions'.

Improbable US Defense & National Security, a subsidiary of UK-based synthetic environment specialist Improbable, has shut down its US defence business.

Information about the closure emerged on 9 December when Improbable US employees began posting about their departure from the company on social media, citing ‘macroeconomic conditions' and the company’s decision to divest its US defence activities.

Both Improbable US and the UK parent were approached by Shephard for comment but no answer had been received at the time of publication.

On 10 December, however, Improbable US president and GM Caitlin Dohrman wrote in a LinkedIn post that ‘Improbable's sudden decision to leave

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 2 free stories per week
  • Personalised news alerts
  • Daily and weekly newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Norbert Neumann

Author

Norbert Neumann


Norbert is the Aviation, Military Training & Simulation reporter at Shephard Media. Before joining Shephard in …

Read full bio

Share to

Linkedin